• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Am Acad Dermatol . The Spectrum of COVID-19-associated Dermatologic Manifestations: An International Registry of 716 Patients From 31 Countries

tetano

Editor, Senior Moderator
J Am Acad Dermatol


. 2020 Jul 2;S0190-9622(20)32126-5.
doi: 10.1016/j.jaad.2020.06.1016. Online ahead of print.
The Spectrum of COVID-19-associated Dermatologic Manifestations: An International Registry of 716 Patients From 31 Countries


Esther E Freeman[SUP] 1 [/SUP], Devon E McMahon[SUP] 2 [/SUP], Jules B Lipoff[SUP] 3 [/SUP], Misha Rosenbach[SUP] 3 [/SUP], Carrie Kovarik[SUP] 3 [/SUP], Seemal R Desai[SUP] 4 [/SUP], Joanna Harp[SUP] 5 [/SUP], Junko Takeshita[SUP] 3 [/SUP], Lars E French[SUP] 6 [/SUP], Henry W Lim[SUP] 7 [/SUP], Bruce H Thiers[SUP] 8 [/SUP], George J Hruza[SUP] 9 [/SUP], Lindy P Fox[SUP] 10 [/SUP]



Affiliations
Free PMC article

Abstract

Background: Coronavirus disease 2019 (COVID-19) has associated cutaneous manifestations.
Objective: To characterize the diversity of cutaneous manifestations of COVID-19, and facilitate understanding of underlying pathophysiology.
Methods: Case series from an international registry from the American Academy of Dermatology and International League of Dermatological Societies.
Results: The registry collected 716 cases of new-onset dermatologic symptoms in patients with confirmed/suspected COVID-19. Of the 171 patients in the registry with laboratory-confirmed COVID-19, the most common morphologies were morbilliform (22%), pernio-like (18%), urticarial (16%), macular erythema (13%), vesicular (11%), papulosquamous (9.9%), and retiform purpura (6.4%). Pernio-like lesions were common in patients with mild disease, while retiform purpura presented exclusively in ill, hospitalized patients.
Limitations: We cannot estimate incidence or prevalence. Confirmation bias is possible.
Conclusion: This study highlights the array of cutaneous manifestations associated with COVID-19. Many morphologies were non-specific, while others may provide insight into potential immune or inflammatory pathways in COVID-19 pathophysiology.

Keywords: COVID toes; COVID-19; SARS-CoV-2; dermatology; global health; macular erythema; morbilliform; pernio; public health; registry; retiform purpura; urticarial; vesicular.
 
Back
Top Bottom